Manolopoulos Konstantinos N, O'Reilly Michael W, Bujalska Iwona J, Tomlinson Jeremy W, Arlt Wiebke
Institute of Metabolism and Systems Research, University of Birmingham B15 2TT, United Kingdom.
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham B15 2TH, United Kingdom.
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1091-1101. doi: 10.1210/jc.2016-3600.
Glucocorticoids have pleiotropic metabolic functions, and acute glucocorticoid excess affects fatty acid metabolism, increasing systemic lipolysis. Whether glucocorticoids exert adipose tissue depot-specific effects remains unclear.
To provide an in vivo assessment of femoral and abdominal adipose tissue responses to acute glucocorticoid administration.
Nine healthy male volunteers were studied on two occasions, after a hydrocortisone infusion (0.2 mg/kg/min for 14 hours) and a saline infusion, respectively, given in randomized double-blind order. The subjects were studied in the fasting state and after a 75-g glucose drink with an in vivo assessment of femoral adipose tissue blood flow (ATBF) using radioactive xenon washout and of lipolysis and glucose uptake using the arteriovenous difference technique. In a separate study (same infusion design), eight additional healthy male subjects underwent assessment of fasting abdominal ATBF and lipolysis only. Lipolysis was assessed as the net release of nonesterified fatty acids (NEFAs) from femoral and abdominal subcutaneous adipose tissue.
Acute hypercortisolemia significantly increased basal and postprandial ATBF in femoral adipose tissue, but the femoral net NEFA release did not change. In abdominal adipose tissue, hypercortisolemia induced substantial increases in basal ATBF and NEFA release.
Acute hypercortisolemia induces differential lipolysis and ATBF responses in abdominal and femoral adipose tissue, suggesting depot-specific glucocorticoid effects. Abdominal, but not femoral, adipose tissue contributes to the hypercortisolemia-induced systemic NEFA increase, with likely contributions from other adipose tissue sources and intravascular triglyceride hydrolysis.
糖皮质激素具有多效性代谢功能,急性糖皮质激素过量会影响脂肪酸代谢,增加全身脂肪分解。糖皮质激素是否对脂肪组织储存部位产生特异性影响尚不清楚。
对急性给予糖皮质激素后股骨和腹部脂肪组织的反应进行体内评估。
9名健康男性志愿者分两次接受研究,分别以随机双盲顺序接受氢化可的松输注(0.2mg/kg/min,持续14小时)和生理盐水输注。在空腹状态和饮用75g葡萄糖饮料后对受试者进行研究,使用放射性氙洗脱法体内评估股骨脂肪组织血流量(ATBF),并使用动静脉差技术评估脂肪分解和葡萄糖摄取。在另一项单独研究(相同的输注设计)中,另外8名健康男性受试者仅接受空腹腹部ATBF和脂肪分解评估。脂肪分解评估为非酯化脂肪酸(NEFA)从股骨和腹部皮下脂肪组织的净释放量。
急性高皮质醇血症显著增加了股骨脂肪组织的基础和餐后ATBF,但股骨NEFA净释放量未改变。在腹部脂肪组织中,高皮质醇血症导致基础ATBF和NEFA释放量大幅增加。
急性高皮质醇血症在腹部和股骨脂肪组织中诱导不同的脂肪分解和ATBF反应,提示糖皮质激素具有储存部位特异性作用。腹部而非股骨脂肪组织导致高皮质醇血症诱导的全身NEFA增加,其他脂肪组织来源和血管内甘油三酯水解可能也有贡献。